Leif Tybring
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
- Microbial Natural Products and Biosynthesis
Papers in
- Pharmacology 14
- Antibiotics Pharmacokinetics and Efficacy 12
- Drug-Induced Adverse Reactions 4
-
- Antibiotic Resistance in Bacteria 7
- Co-authors
- K Roholt (6 shared papers)W. O. Godtfredsen (6 shared papers)F Lund (3 shared papers)W. von Daehne (3 shared papers)Hans J. Petersen (1 shared paper)Steen Vangedal (2 shared papers)Fleming Güttler (1 shared paper)AKSEL BIRCH‐ANDERSEN (1 shared paper)
In The Last Decade
Leif Tybring
25 papers receiving 821 citations
Peers
Comparison fields: 5 of 95
- Molecular Medicine 261
- Pharmacology 424
- Infectious Diseases 187
- Clinical Biochemistry 64
- Applied Microbiology and Biotechnology 16
Countries citing papers authored by Leif Tybring
This map shows the geographic impact of Leif Tybring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leif Tybring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leif Tybring more than expected).
Fields of papers citing papers by Leif Tybring
This network shows the impact of papers produced by Leif Tybring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leif Tybring. The network helps show where Leif Tybring may publish in the future.
Co-authors
The 16 scholars most cited alongside Leif Tybring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1962 | 182 | |
| 2 | 1972 | 177 | |
| 3 | 1970 | 138 | |
| 4 | 1962 | 132 | |
| 5 | 1975 | 93 | |
| 6 | Pivampicillin, a new orally active ampicillin ester. | 1970 | 54 |
| 7 | 1975 | 47 | |
| 8 | 1966 | 41 | |
| 9 | 1973 | 32 | |
| 10 | 1971 | 27 | |
| 11 | 1975 | 18 | |
| 12 | 1969 | 14 | |
| 13 | 1974 | 11 | |
| 14 | 1962 | 11 | |
| 15 | 1976 | 6 | |
| 16 | Transformations of fusidic acid and the relationship between structure and antibacterial activity. | 1965 | 6 |
| 17 | 1977 | 5 | |
| 18 | 1957 | 4 | |
| 19 | [Fucidin, a new antibiotic for peroral therapy]. | 1962 | 4 |
| 20 | 1979 | 4 |
About Leif Tybring
Leif Tybring is a scholar working on Pharmacology, Molecular Medicine, Pharmacology, Analytical Chemistry and Infectious Diseases, having authored 25 papers that have together received 1.0k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Antibiotic Resistance in Bacteria (7 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers), Drug-Induced Adverse Reactions (4 papers), Analytical Methods in Pharmaceuticals (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Pharmaceutical studies and practices (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). The work is most often cited by research in Molecular Medicine (261 citations), Pharmacology (424 citations), Infectious Diseases (187 citations), Clinical Biochemistry (64 citations) and Applied Microbiology and Biotechnology (16 citations). Leif Tybring has collaborated with scholars based in Denmark and Australia. Frequent co-authors include K Roholt, W. O. Godtfredsen, F Lund, W. von Daehne, Hans J. Petersen, Steen Vangedal, Fleming Güttler, AKSEL BIRCH‐ANDERSEN, Jens Blom and R Vejlşgaard. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Medicinal Chemistry, Journal of Antimicrobial Chemotherapy, Nature and The Journal of Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.